BROADCASTS.com

b'

This week we review Dr. Rory Spiegel\'s EMNerd\\xa0blog post,\\xa0A\\xa0Case of Identity Part Two, on dual antiplatelet therapy for ACS and MI.\\xa0

\\n
• Dual antiplatelet therapy, often aspirin + P2Y12 inhibitors, although commonly used, do not affect mortality and have questionable benefit but are associated with risks of bleeding.
\\n

Then, we delve into core content pearls on anticoagulation including aspirin, ibuprofen, and novel oral anticoagulants using Rosenalli\\xa0\\xa0(Rosen\'s Emergency Medicine and Tintinalli\'s Emergency Medicine: A Comprehensive Review Guide) and Goldrank (10th ed) Chapter 60 and EMPractice October 2013 as a guide. \\xa0

As always, visit\\xa0foamcast.org\\xa0for show notes and the generously donated Rosh Review questions.

Thanks y\'all!

-Jeremy Faust and Lauren Westafer